BioCryst Pharmaceuticals
BCRX
BCRX
233 hedge funds and large institutions have $2.09B invested in BioCryst Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 67 increasing their positions, 71 reducing their positions, and 21 closing their positions.
Holders
233
Holders Change
+27
Holders Change %
+13.11%
% of All Funds
3.69%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
50
Increased
67
Reduced
71
Closed
21
Calls
$92M
Puts
$34.8M
Net Calls
+$57.2M
Net Calls Change
+$18M
